Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719339 · ClinicalTrials.gov registry record
VIRTUUS Children's Study
A clinical trial of End Stage Renal Disease and Antibody-mediated Rejection, sponsored by Children's Hospital of Philadelphia.
- Active
- Registry status
- 445
- Enrollment target
- 13
- Study locations
NCT03719339 is a study of End Stage Renal Disease and Antibody-mediated Rejection that is active but no longer recruiting, run by Children's Hospital of Philadelphia. The registered enrollment target is 445 participants, below the 828-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (46% lower). The trial reports 13 study locations across 9 states.
The verdict
NCT03719339, a study of End Stage Renal Disease and Antibody-mediated Rejection, is active but no longer recruiting, sponsored by Children's Hospital of Philadelphia.
- ACTIVE NOT RECRUITING
- Registry status
- 445 participants
- Enrollment target
- 13
- Study locations
Study Summary
The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.
Conditions Studied
Study Locations (13)
California
- University of California-San Diego, Rady Children's Hospital - La Jolla
- Children's Hospital Los Angeles - Los Angeles
- University of California - Los Angeles
- Stanford University - Palo Alto
Pennsylvania
- CHOP - Philadelphia
- University of Pennsylvania - Philadelphia
District of Columbia
- Children's National Medical Center - Washington D.C.
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Minnesota
- University of Minnesota - Minneapolis
New York
- Joan & Sanford I. Weill Medical College of Cornelle University - New York
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2017-08-10 |
| Est. Completion | 2026-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03719339
The ClinicalTrials.gov registry entry for NCT03719339 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 445 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 828-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (46% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03719339 reports 13 study locations spanning 9 distinct geographic areas - top geographies include California, Pennsylvania, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03719339 about?
NCT03719339 is a clinical study titled "VIRTUUS Children's Study". The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.
What is the current status of trial NCT03719339?
This trial is currently active not recruiting. The enrollment target is 445 participants. The study started on 2017-08-10. Estimated completion is 2026-03-31.
What conditions does trial NCT03719339 study?
This clinical trial studies the following conditions: End Stage Renal Disease, Antibody-mediated Rejection, Nephropathy, Pediatric Kidney Disease, Renal Transplant Rejection.
Who is sponsoring clinical trial NCT03719339?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03719339 being conducted?
This trial has 13 study locations across California, District of Columbia, Illinois, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
RECRUITING
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
RECRUITING · Phase 1
-
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.